Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis

Overview of attention for article published in Vaccine, September 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

patent: 6 patents

Readers on

mendeley: 65 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents

Grant US-11590083-B2

United States of America

28 Feb 2023

VACCINE

Application WO-2021028697-A1

World Intellectual Property Organisation (WIPO)

18 Feb 2021

Gastrointestinal site-specific oral vaccination formulations active on the ileum and…

Grant US-10588857-B2

United States of America

17 Mar 2020

Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents

Grant US-10369111-B2

United States of America

06 Aug 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.